Remibrutinib Improves Chronic Spontaneous Urticaria in Patients Irrespective of Previous Anti-IgE Treatment: Results From a Phase 2b Study

被引：0
|
作者：
Greiner, Alexander [1 ,2 ]
Guduri, Sridhar [3 ]
Leflein, Jeffrey [4 ]
Haemmerle, Sibylle [5 ]
Lheritier, Karine [5 ]
Walsh, Pauline [6 ]
Nikolaev, Ivan [5 ]
Gimenez-Arnau, Ana [7 ]
Maurer, Marcus [8 ]
机构：
[1] Allergy & Asthma Med Grp & Res Ctr, San Diego, CA USA
[2] Univ Calif San Diego, San Diego, CA USA
[3] Centricity Res Inc, Columbus, OH USA
[4] Resp Med Res Inst Michigan, Ann Arbor, MI USA
[5] Novartis Pharma AG, Basel, Switzerland
[6] Novartis Ireland Ltd, Dublin, Ireland
[7] Univ Pompeu Fabra, Hosp Mar IMIM, Barcelona, Spain
[8] Charit Univ Med Berlin, Urticaria Ctr Reference & Excellence UCARE, Berlin, Germany
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2023年 / 151卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
404
引用
收藏
页码：AB131 / AB131
页数：1
相关论文
共 50 条
  • [1] Remibrutinib (LOU064) treatment improves chronic spontaneous urticaria in patients irrespective of previous anti-IgE treatment: Phase 2b study results
    Metz, M.
    Greiner, A.
    Guduri, S.
    Leflein, J.
    Haemmerle, S.
    Lheritier, K.
    Walsh, P.
    Nikolaev, I.
    Gimenez-Arnau, A. M.
    Maurer, M.
    ALLERGY, 2023, 78 : 245 - 246
  • [2] REMIBRUTINIB IMPROVES CHRONIC SPONTANEOUS URTICARIA IN PATIENTS IRRESPECTIVE OF CU-INDEX: RESULTS FROM PHASE 2B STUDY
    Carr, W.
    Sitz, K.
    Jain, V.
    Gimenez-Arnau, A.
    Lheritier, K.
    Nikolaev, L.
    Haemmerle, S.
    Maurer, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 : S11 - S11
  • [3] REMIBRUTINIB TREATMENT IMPROVES HIVE SEVERITY IN PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA: PHASE 2B STUDY RESULTS
    Sitz, K.
    Gimenez-Arnau, A.
    Hayama, K.
    Jain, V.
    Lheritier, K.
    Walsh, P.
    Haemmerle, S.
    Maurer, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (05) : S11 - S11
  • [4] Remibrutinib Treatment Improves Itch and Sleep in Chronic Spontaneous Urticaria Patients: Phase 2b Study Results
    Hsu, Connie
    Snyder, Robert
    Clore, Lee
    Jain, Vipul
    Gimenez-Arnau, Ana
    Lheritier, Karine
    Walsh, Pauline
    Haemmerle, Sibylle
    Wells, Michael
    Nikolaev, Ivan
    Maurer, Marcus
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB82 - AB82
  • [5] REMIBRUTINIB TREATMENT IMPROVES SLEEP AND ACTIVITY IN CHRONIC SPONTANEOUS URTICARIA PATIENTS: PHASE 2B STUDY RESULTS
    Clore, L.
    Jain, V.
    Gimenez-Arnau, A.
    Lheritier, K.
    Walsh, P.
    Haemmerle, S.
    Maurer, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 : S32 - S32
  • [6] Remibrutinib (LOU064) treatment improves hive severity in patients with chronic spontaneous urticaria: Findings from a Phase 2b study
    Gimenez-Arnau, A. M.
    Hayama, K.
    Jain, V.
    Sitz, K.
    Lheritier, K.
    Nikolaev, I.
    Walsh, P.
    Haemmerle, S.
    Maurer, M.
    ALLERGY, 2023, 78 : 245 - 245
  • [7] REMIBRUTINIB SHOWED GOOD STABILITY OF RESPONSE IN PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA: PHASE 2B STUDY
    Tillinghast, J.
    Jain, V.
    Maurer, M.
    Gimenez-Arnau, A.
    Reich, A.
    Ortmann, C.
    Walsh, P.
    Haemmerle, S.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (05) : S41 - S41
  • [8] Remibrutinib Treatment Has No Impact on Blood Counts in Patients With Chronic Spontaneous Urticaria: Results From Phase 2b 52-week Extension Study Results
    Greiner, Alexander
    Jain, Vipul
    Gimanez-Armau, Ana
    Tillinghast, Jeffrey
    Lheritier, Karine
    Walsh, Pauline
    Haemmerle, Sibylle
    Zharkov, Artem
    Snyder, Robert
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB3 - AB3
  • [9] Remibrutinib Treatment Did Not Impact Total Serum Immunoglobulin Levels or Infection Rates in Patients With Chronic Spontaneous Urticaria: Phase 2b Study Results
    Carr, Warner
    Gimanez-Armau, Ana
    Lheritler, Karine
    Haemmerle, Sibylle
    Zharkov, Artem
    Dahale, Swapnil
    Hayama, Koremasa
    Snyder, Robert
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB8 - AB8
  • [10] Remibrutinib monotherapy reduced rescue medication in chronic spontaneous urticaria patients: Findings from a Phase 2b extension study
    Clore, Lee
    Carr, Warner
    Tillinghast, Jeffrey
    Jain, Vipul
    Reed, John
    Staubach, Petra
    Lheritier, Karine
    Walsh, Pauline
    Nikolaev, Ivan
    Haemmerle, Sibylle
    Gimenez-Arnau, Ana Maria
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB6 - AB6
12345